Skip to main content

Table 1 Summary of stakeholder involvement

From: Development of a core outcome set for clinical trials in rosacea: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey

Key stakeholders

 

Physicians (including dermatologists, international providers, physicians of other health care fields)

 

Patients

 

Drug and device safety regulators (e.g., FDA, EMA)

 

National Rosacea Society/support groups

 

Pharmacologists/pharmacists

 

Industry scientists

 

Nurses, physician assistants, or other health care providers

 
  1. EMA European Medicines Agency, FDA US Food and Drug Administration
Back to article page

Trials

ISSN: 1745-6215